- Comparative Effects of Ibandronate and Paclitaxel on Immunocompetent Bone Metastasis Model
-
Chung YS, Kang HC, Lee T
- KMID: 2345895
- Yonsei Med J.
- 2015 Nov;56(6):1643-1650.
- doi: 10.3349/ymj.2015.56.6.1643
PURPOSE: Bone metastasis invariably increases morbidity and mortality. This study compares the effects of ibandronate and paclitaxel on bone structure and its mechanical properties and biochemical turnover in resorption markers... -
- CITED
-
- Close
- SHARE
-
- Close
- Pathological responses to preoperative high-dose methotrexate chemotherapy in osteosarcoma: experience in Korea cancer hospital
-
Lee SY, Jeon DG, Kim SS, Jang JJ, Cho KJ
- KMID: 1421963
- J Korean Med Sci.
- 1993 Apr;8(2):121-126.
- doi: 10.3346/jkms.1993.8.2.121
During the last decade, many clinical investigators at various cancer centers have reported the efficacy of various chemotherapeutic agents in the treatment of osteosarcoma. The regimens using high-dose methotrexate (HDMTX)... -
- CITED
-
- Close
- SHARE
-
- Close
- Bisphosphonate enhances TRAIL sensitivity to human osteosarcoma cells via death receptor 5 upregulation
-
Moon MH, Jeong JK, Seo JS, Seol JW, Lee YJ, Xue M, Jackson CJ, Park SY
- KMID: 1109402
- Exp Mol Med.
- 2011 Mar;43(3):138-145.
- doi: 10.3858/emm.2011.43.3.016
Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL), a member of the TNF superfamily of cytokines, is one of the most promising candidates for cancer therapeutics. However, many osteosarcomas are resistant... -
- CITED
-
- Close
- SHARE
-
- Close
- Long-Term Survivals of Stage IIB Osteosarcoma: A 20-Year Experience in a Single Institution
-
Cho Y, Jung GH, Chung SH, Kim JY, Choi Y, Kim JD
- KMID: 999460
- Clin Orthop Surg.
- 2011 Mar;3(1):48-54.
- doi: 10.4055/cios.2011.3.1.48
BACKGROUND: The purpose of this study is to evaluate the disease-free survival (DFS) and overall survival (OS) of patients with stage IIB osteosarcoma at a single institution for 20 years... -
- CITED
-
- Close
- SHARE
-
- Close
